DAREEarnings•globenewswire•
Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Sentiment:Positive (70)
Summary
DARE to PLAY™ Sildenafil Cream on Track for Q4 2025 Launch via 503B Compounding Pathway; Positioned for Product Revenue Beginning in Q4 2025
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 14, 2025 by globenewswire